Serum PFOS Concentration and Isomer Composition in Relation to Depressive Symptoms in Young Adults
- 1Key Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University; Department of Neurology, The Second Hospital of Hebei Medical University;
Abstract
Total serum perfluorooctane sulfonate (PFOS) concentration and its isomer composition describe different aspects of internal exposure, but their respective associations with depressive symptoms remain uncertain. We examined adults aged 18-25 years in NHANES August 2021-August 2023 using survey-weighted models of the Patient Health Questionnaire-9 (PHQ-9). Total measured PFOS was the sum of linear PFOS and pooled monomethyl-branched PFOS; composition was their log-ratio. The analytic cohort included 169 participants, with 147 complete cases for core adjustment. Median total PFOS was 1.70 ng/mL, the median linear fraction was 72.2%, and the weighted prevalence of PHQ-9 [≥]10 was 22.6%. In the joint adjusted model, a doubling of total PFOS at fixed composition corresponded to -0.49 PHQ-9 points (95% CI, -1.65 to 0.68); a doubling of the linear-to-branched ratio at fixed total corresponded to 0.21 points (-1.94 to 2.36). Algebraic rescaling across the reported interquartile ranges yielded differences of -0.58 points (-1.95 to 0.81) for total PFOS and 0.13 points (-1.16 to 1.41) for composition. The inverse continuous-score association weakened with adjustment, whereas the screening odds ratio primarily lost precision. Excluding three observations with an isomer below detection shifted both joint coefficients. The data therefore do not establish an independent composition association or equivalent isomer effects. Experimental evidence supports candidate oxidative, inflammatory, and synaptic pathways, but differential protein binding and elimination prevent a serum composition ratio from being interpreted directly as brain dose or toxicity. Larger longitudinal analyses with isomer-resolved exposure and toxicokinetic measurements are needed to test these pathways.
Related
- Coexisting low bone mass and low muscle phenotype in relation to falls and depressive symptoms among Korean adults: a nationally representative cross-sectional study
- Physical intimate partner violence during pregnancy and maternal social context in relation to postpartum depressive symptoms in the United States
- Sleep disturbance and its associations with night shift work, anxiety symptoms, and depressive symptoms among urban operation-supporting workers: a cross-sectional study
- Self-reported pain, depressive symptoms and risk for cardiovascular diseases
- Association of Milk and Dairy Intake with Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-Analysis
BibTeX
@misc{bi2026serum,
title = {{Serum PFOS Concentration and Isomer Composition in Relation to Depressive Symptoms in Young Adults}},
author = {Y. Bi and Y. Liu and Y. Li and H. Bu},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.14.26365394},
url = {https://www.medrxiv.org/content/10.64898/2026.10.14.26365394v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Serum PFOS Concentration and Isomer Composition in Relation to Depressive Symptoms in Young Adults
AU - Y. Bi
AU - Y. Liu
AU - Y. Li
AU - H. Bu
PY - 2026
DA - 2026/10/14
PB - medRxiv
DO - 10.64898/2026.10.14.26365394
UR - https://www.medrxiv.org/content/10.64898/2026.10.14.26365394v1
AB - Total serum perfluorooctane sulfonate (PFOS) concentration and its isomer composition describe different aspects of internal exposure, but their respective associations with depressive symptoms remain uncertain. We examined adults aged 18-25 years in NHANES August 2021-August 2023 using survey-weighted models of the Patient Health Questionnaire-9 (PHQ-9). Total measured PFOS was the sum of linear PFOS and pooled monomethyl-branched PFOS; composition was their log-ratio. The analytic cohort included 169 participants, with 147 complete cases for core adjustment. Median total PFOS was 1.70 ng/mL, the median linear fraction was 72.2%, and the weighted prevalence of PHQ-9 [≥]10 was 22.6%. In the joint adjusted model, a doubling of total PFOS at fixed composition corresponded to -0.49 PHQ-9 points (95% CI, -1.65 to 0.68); a doubling of the linear-to-branched ratio at fixed total corresponded to 0.21 points (-1.94 to 2.36). Algebraic rescaling across the reported interquartile ranges yielded differences of -0.58 points (-1.95 to 0.81) for total PFOS and 0.13 points (-1.16 to 1.41) for composition. The inverse continuous-score association weakened with adjustment, whereas the screening odds ratio primarily lost precision. Excluding three observations with an isomer below detection shifted both joint coefficients. The data therefore do not establish an independent composition association or equivalent isomer effects. Experimental evidence supports candidate oxidative, inflammatory, and synaptic pathways, but differential protein binding and elimination prevent a serum composition ratio from being interpreted directly as brain dose or toxicity. Larger longitudinal analyses with isomer-resolved exposure and toxicokinetic measurements are needed to test these pathways.
ER -